FDA
- FDA Finalizes Food Chemical Safety Post-Market Assessment Program
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- How FDA is Implementing Landmark Cosmetics Legislation to Positively Impact Public Health
- FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S.
- OTC Monograph Drug User Fee Amendments (OMUFA)
- Outbreak Investigation of E. coli O157:H7: Raw Cheddar Cheese
- FDA Announces Public Meeting on Challenges and Solutions for Lot-Level Traceability
- FDA Finds Six Additional Cosmetic Products Marketed as Gel Nail Polish Remover To Contain Methylene Chloride
- FDA Releases FY25 Sampling Results on Economically Motivated Adulteration in Honey
- Outbreak Investigation of E. coli O157:H7: Raw Cheddar Cheese
- Food Safety Culture Webinar
- FDA Announces OTC Monograph Drug Facility Fee Rates for Fiscal Year 2026
- FDA Issues Guidance on Form 483 Responses
- FDA Takes Steps to Improve Gluten Ingredient Disclosure in Foods
- FDA Withdraws Two Temporary COVID FSMAÂ Guidances
- FDA Releases the CORE 2024 Annual Report: Investigations of Foodborne Outbreaks and Adverse Events in FDA-Regulated Foods
- FDA Launches New Adverse Event Look-Up Tool
- Outbreak Investigation of Infant Botulism: Infant Formula
- FDA Augments and Improves Infant Formula Resources to Enhance Transparency, Safety, and Access for American Families
- FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s
- FDA Announces Public Meeting on Dietary Supplement Innovation and the Scope of Dietary Ingredients
- FDA Takes Several Actions Related to the Food Traceability Rule
- Outbreak Investigation of Extensively Drug-Resistant Salmonella: Moringa Powder
- FDA Launches Assessment of BHA, a Common Food Chemical Preservative
- FDA implements QMSR: Medical device inspections to be conducted under an updated process
- FDA Releases Human Food Program (HFP) 2026 Priority Deliverables
- Event Materials Available for the Virtual Public Meeting and Listening Sessions on Food Allergen Thresholds and Their Potential Applications
- FDA Takes Steps to Improve Gluten Ingredient Disclosure in Foods
- FDA Announces PreCheck Implementation Roadmap
- FDA Report Flags Uncertainty Over PFAS Safety in Cosmetics
- FDA VQIP FY2027 Portal Now Open for Importers
- PFAS in Food Update from 2024 Tests
- FDA Warns Retailers After ByHeart Formula Recall Fails to Protect Infants
- CORE Outbreak Investigation Table
- 2024 FDA Food Code Adoption by State | Restaurant Oversight
- Outbreak Investigation of Salmonella: Moringa Leaf Powder
- Â The Voluntary Qualified Importer Program (VQIP)Â
- Outbreak Investigation of Infant Botulism: Infant Formula
- FDA Issues Warning About Imported Cookware That May Leach Lead
- FDA Announces First Use of Import Certification Authority for Certain Shrimp and Spices Potentially Contaminated with Cesium-137
- FDA releases results on economically motivated adulteration (short weighting) in seafood
- FDA Proposes Revocation of Authorization for Orange B in Food
- More Ground Cinnamon Products Added to FDA Public Health Alert Due to Presence of Elevated Levels of Lead
- FDA Issues Warning About Imported Cookware That May Leach Lead
- FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products
- FDA News Release FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging
- FDA releases results on economically motivated adulteration (short weighting) in seafood
- Half-shell Oysters from Republic of Korea Potentially Contaminated with Norovirus
- FDA Update on Post-market Assessment of Chemicals in the Food Supply
- Submit Application in the VQIP Portal for FY2026 Benefits
- FDA Issues Warning About Imported Cookware That May Leach Lead
- FDA Announces New FDA PreCheck Program to Boost U.S. Drug Manufacturing
- FDA Commissioner Makary, USDA Secretary Rollins Celebrate Proposed Modernization of Orange Juice Regulations to Benefit American Growers
- FDA Issues Proposed Rule to Amend Standard of Identity for Pasteurized Orange Juice
- FDA Proposes to Extend Compliance Date for Food
- FDA Releases New Tool for Toxicity Screening of Chemicals in Food
- FDA Announces FY2026 User Fees for VQIP and TPP
- FDA Implementing Nationalized Entry Review Program – Important Changes Effective August 4, 2025
- RUF Releases Produce Safety Roadmap
- HHS, FDA and USDA Address the Health Risks of Ultra-Processed Foods
- FDA to Revoke 52 Obsolete Standards of Identity for Food Products
- FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine
- Food Importer News from the U.S. FDA
- Notice to Industry on FDA Imports Review Exemption Change
- Notice to Industry on FDA imports review exemption change
- FDA Extends Comment Period for Proposed Method for Ranking Chemicals in Food for Post-market Assessments
- FDA Approves Gardenia (Genipin) Blue Color Additive While Encouraging Faster Phase-Out of FD&C Red No. 3
- FDA Encourages Food Manufacturers to Accelerate Phasing Out the Use of FD&C Red No. 3 in Foods Before 2027 Deadline
- FDA Updates General Food Labeling Requirements Compliance Program
- FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests
- US Food and Drug Administration FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
- Fiscal Year 2025 OMUFA Facility User Fee Due Date
- Outbreak Investigation of Salmonella: Cucumbers
- FDA Approves Three Food Colors from Natural Sources
- FDA Advises Consumers, Retailers, and Distributors Not to Eat, Sell, or Serve Products from Pan-African Food Distributors Inc. dba East Africa Boutique LLC
- FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms
- FDA Alerts Industry and Consumers about Palm Leaf Dinnerware
- FDA Advances Robust, Transparent Post-Market Chemical Review Program to Keep Food Supply Safe and Healthy
- FDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market
- ​​​​FDA 101: Product Recalls
- HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula
- FDA Advises Consumers, Tattoo Artists, and Retailers to Avoid Using or Selling Certain Sacred Tattoo Ink Products Contaminated with Microorganisms
- FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program
- FDA Approves Three Food Colors from Natural Sources
- FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline
- Front-of-Package Labeling Comment Period Extension
- OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2025 User Fees and Registration
- FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
- US Food and Drug Administration HHS, FDA Announce Operation Stork Speed to Expand Options for Safe, Reliable, and Nutritious Infant Formula for American Families
- FDA Adds Firms to Import Alert Due to PFAS in Clams
- FDA Revokes Use of FD&C Red No.3 in Foods and Drugs
- FDA Announces Release of Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market
- FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products
- FDA Issues Letter to Retailers and Distributors Concerning Lead in Certain Imported Cookware
- FDA Releases Guidance on Voluntary Premarket Engagement for Foods Derived from Plants Produced Using Genome Editing
- FDA Announces European Union (EU) Requirements for All Honey and Other Apiculture Products Imported into the EU
- FDA Reminds OTC Hand Sanitizer Manufacturers of OMUFA Facility Fees for FY 2025
- USDA-FDA Seek Information About Food Date Labeling, Aim is to Provide Further Clarity, Transparency, and Cost Savings for U.S. Consumers
- FDA Updates Guidance for the Voluntary Qualified Importer Program (VQIP)
- FDA Seeks Public Input on Experiences with Export Certification in the Form of Lists (Export Lists) for Human Food Products
- FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active Ingredient After Extensive Review
- FDA Human Foods Program: FY 2025 Priority Deliverables
- FDA Releases Supplement to the 2022 Food Code
- The FDA Updates Mycotoxins in Domestic and Imported Human Foods Compliance Program
- FDA Issues Warning About Certain Supplements Substituted with Toxic Yellow Oleander
- FDA Reminds Animal and Human Food Facilities to Register or Renew their Food Facility Registration (FFR) between October 1 and December 31, 2024
- FDA Releases Informational Video on Importing Seafood
- FDA is aware of concerns about tampon safety
- FDA Announces New Sodium Reduction Targets in Phase II Efforts
- FDA Proposed Rule for Submission Tracking Numbers on E-Cigarette Imports
- FDA Issues Warning Letter to Austrofood: Ensuring Safety of Cinnamon Products
- FDA India Office Addresses Safety and Regulatory Issues for Herbal and Ayurvedic Products
- FDA Announces FY 2025 OTC Monograph Order Request (OMOR) Fee Rates
- FDA Updates: Fiscal Year 2025 User Fees, Health Alerts, and More
- FDA Warns Consumers Not to Use OPMS Black Liquid Kratom
- FDA Report on Fresh Herbs Sampling Assignment
- FDA Hosts Public Meeting on Home as a Health Care Hub
- FDA Issues Warning to Bimbo Bakeries USA Over Mislabeling Major Food Allergens
- Potential Device Failures of Plastic Syringes Made in China
- FDA issued an additional warning letter that describes violations related to the sale and distribution of unauthorized plastic syringes
- FDA Alert Concerning Certain Cinnamon Products Due to Presence of Elevated Levels of Lead
- FDA Issues Updated Compliance Program for Infant Formula
